Evaluation of Raltegravir During the Third Trimester of Pregnancy

NCT02099474 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV-1 Infection
PREGNANCY

Interventions

OTHER: Study of pharmacokinetic properties of raltegravir during the 3rd trimester of pregnancy

Sponsor

ANRS, Emerging Infectious Diseases